108
EQT-owned skin-care group, Galderma, has announced its intention to conduct an IPO on the SIX Swiss Exchange, marking the next step of Galderma’s growth trajectory as a pure-play dermatology company. The IPO could raise as much as US$2.3bn, according to Bloomberg.
The news comes on the back of the company reporting positive full-year earnings.
It achieved US$4.082bn in net sales in FY2023, up 8.5% year on year, surpassing US$4bn in net sales for the first time.
Core EBITDA for 2023 was US$942m, representing a 23.1% core EBITDA margin,…